Accounts Payable Specialist
Virta HealthFull Time
Entry Level & New Grad
Key technologies and capabilities for this role
Common questions about this position
The expected base salary is generally between $75,000 - $85,000 per year at the commencement of employment, though the final salary may vary based on individual circumstances, experience, business needs, and market conditions.
The position is hybrid and located in NYC.
Candidates need 2+ years of relevant experience, knowledge of Excel and major ERP systems (NetSuite and Coupa a plus), process-oriented mindset, attention to detail, effective internal controls, cross-departmental collaboration, high organization, and strong communication skills.
Roivant embraces diversity across all dimensions, hires motivated people with diverse backgrounds, and fosters an inclusive culture where employees feel valued, respected, and empowered.
Strong candidates will have 2+ years of relevant experience, preferably in pharmaceuticals with clinical trials, proficiency in Excel and ERP systems like NetSuite or Coupa, and demonstrate process orientation, attention to detail, organization, communication, and cross-departmental effectiveness.
Develops biopharmaceuticals and RNA therapeutics
Roivant Sciences develops and delivers medicines and technologies aimed at improving patient health, focusing on drug candidates for genetic disorders and RNA therapeutics. The company operates in the biopharmaceutical market, which involves creating drugs from biological sources. Roivant's unique business model combines in-house development with strategic partnerships, allowing it to build a strong pipeline of drug candidates and utilize advanced technologies to meet medical needs. A key subsidiary, Genevant, specializes in RNA therapeutics, employing proprietary delivery platforms for mRNA, RNAi, and gene editing to treat specific diseases. Roivant generates revenue through drug development, licensing agreements, and partnerships, with the goal of bringing innovative treatments to market efficiently.